Clover (ASX:CLV) YoY EBITDA Growth: 57.69% (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:CLV Clover Corp Ltd ASX:CLV
55 GF Score
Price A$1.00
GF Value A$0.79
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Clover YoY EBITDA Growth?

Clover ASX:CLV +1.01% 55 YoY EBITDA Growth is 57.69% as of Jan. 2026. GuruFocus rates ASX:CLV with a GF Score™ of 55/100 and a GF Value™ of A$0.79 (Modestly Overvalued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Clover's YoY EBITDA Growth for the quarter that ended in Jan. 2026 was 57.69%.

Clover's EBITDA per Share for the six months ended in Jan. 2026 was A$0.04.

Clover YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Clover's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover YoY EBITDA Growth Chart

Clover Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -50.44 17.86 -9.09 -60.00 204.17

Clover Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -94.29 -12.00 1,200.00 118.18 57.69
ASX:CLV
55GF Score
Clover Corp Ltd ASX:CLV
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Clover's YoY EBITDA Growth for the fiscal year that ended in Jul. 2025 is calculated as:

YoY EBITDA Growth (A: Jul. 2025 )
=(EBITDA per Share (A: Jul. 2025 )-EBITDA per Share (A: Jul. 2024 ))/ | EBITDA per Share (A: Jul. 2024 ) |
=(0.073-0.024)/ | 0.024 |
=204.17 %

Clover's YoY EBITDA Growth for the quarter that ended in Jan. 2026 is calculated as:

YoY EBITDA Growth (Q: Jan. 2026 )
=(EBITDA per Share (Q: Jan. 2026 )-EBITDA per Share (Q: Jan. 2025 )) / | EBITDA per Share (Q: Jan. 2025 )) |
=(0.041-0.026)/ | 0.026 |
=57.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 57.69% mean?
Clover (ASX:CLV) has a YoY EBITDA Growth of 57.69% as of Jan. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Clover and its competitors.
Is Clover's YoY EBITDA Growth too high?
Clover's current YoY EBITDA Growth is 57.69%. Overall, Clover has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover's YoY EBITDA Growth compare to KHC and GIS?
Clover's YoY EBITDA Growth of 57.69% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Consumer Packaged Goods company?
A good YoY EBITDA Growth depends on the Consumer Packaged Goods industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Clover and its competitors. Clover's current YoY EBITDA Growth is 57.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover stock overvalued right now?
Based on GuruFocus' analysis, Clover (ASX:CLV) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.79, compared to a current price of A$1.00 — trading 26.6% above its estimated fair value. The current YoY EBITDA Growth is 57.69%. Clover's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Clover (ASX:CLV), the current YoY EBITDA Growth is 57.69% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover (ASX:CLV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover stock appears to be overvalued. The current stock price of A$1.00 is trading 26.6% above its estimated GF Value™ of A$0.79. GuruFocus considers Clover to be Modestly Overvalued.

Key valuation signals for ASX:CLV:

  • YoY EBITDA Growth: 57.69%
  • GF Value™: A$0.79 vs. price of A$1.00 (26.6% above fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the ASX:CLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Business Description

Address 39 Pinnacle Road, Altona North, Melbourne, VIC, AUS, 3025
Clover Corp Ltd provides nutritional and functional ingredients. The company is involved in the production of encapsulated powders, and research and product development of functional food and infant nutrition ingredients. It offers Nu-Mega Hi docosahexaenoic acid tuna oils for use in infant formula and pharmaceutical products; and Ocean Gold refined tuna oils. Its products include DHA oils, DHA powders, and Microencapsulation. Geographically, the group has a business presence in Australia, New Zealand, Asia, Europe and the Americas. Majority of the revenue is derived from Australia/New Zealand.
55GF Score

Get the complete analysis for ASX:CLV

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.00
Price
A$0.79
GF Value